Petra Baumgaertner

6.2k total citations · 4 hit papers
51 papers, 4.0k citations indexed

About

Petra Baumgaertner is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Petra Baumgaertner has authored 51 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Immunology, 32 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in Petra Baumgaertner's work include Immunotherapy and Immune Responses (35 papers), CAR-T cell therapy research (24 papers) and T-cell and B-cell Immunology (24 papers). Petra Baumgaertner is often cited by papers focused on Immunotherapy and Immune Responses (35 papers), CAR-T cell therapy research (24 papers) and T-cell and B-cell Immunology (24 papers). Petra Baumgaertner collaborates with scholars based in Switzerland, United States and Belgium. Petra Baumgaertner's co-authors include Daniel E. Speiser, Kaat de Jonge, David Gfeller, Julien Racle, Pedro Romero, Nathalie Rufer, Olivier Michielin, Emanuela Romano, Estelle Devêvre and Christiane Meyer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Petra Baumgaertner

51 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data

2017 880 citations Kaat de Jonge, Petra Baumgaertner et al. profile →
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients

2011 650 citations Lukas Baitsch, Petra Baumgaertner et al. Journal of Clinical Investigation profile →
Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients

2015 460 citations Emanuela Romano, Petra Baumgaertner et al. Proceedings of the National Academy of Sciences profile →
Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab

2013 450 citations Laurène Cagnon, Petra Baumgaertner et al. profile →

Peers

Countries citing papers authored by Petra Baumgaertner

Since Specialization

Citations

This map shows the geographic impact of Petra Baumgaertner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Baumgaertner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Baumgaertner more than expected).

Fields of papers citing papers by Petra Baumgaertner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Baumgaertner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Baumgaertner. The network helps show where Petra Baumgaertner may publish in the future.

Co-authorship network of co-authors of Petra Baumgaertner

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Baumgaertner. A scholar is included among the top collaborators of Petra Baumgaertner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Baumgaertner. Petra Baumgaertner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma 2023 ·Cancer Research ·Lorenza P. Ferretti, (unknown), Deena M. Leslie Pedrioli, Phil F. Cheng, (unknown), Petra Baumgaertner, (unknown), (unknown), (unknown), Patrick Turko, Roni H. G. Wright, Katrien De Bock, Daniel E. Speiser, Roberto Ferrari, Mitchell P. Levesque, Michael O. Hottiger	11
2	A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma 2021 ·Cancers ·Alexandre Harari, (unknown), Kaat de Jonge, Anne‐Christine Thierry, Florian Huber, Caroline Boudousquié, (unknown), Angela Orcurto, Martina Imbimbo, Petra Baumgaertner, Michal Bassani‐Sternberg, Lana E. Kandalaft	6
3	Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines 2020 ·Vaccines ·Michele Graciotti, Fabio Marino, HuiSong Pak, Petra Baumgaertner, Anne‐Christine Thierry, Johanna Chiffelle, Marta A. S. Perez, Vincent Zoete, Alexandre Harari, Michal Bassani‐Sternberg, Lana E. Kandalaft	15
4	The C-terminal extension landscape of naturally presented HLA-I ligands 2018 ·Proceedings of the National Academy of Sciences ·Philippe Guillaume, S. Picaud, Petra Baumgaertner, Nicole Montandon, Julien Schmidt, Daniel E. Speiser, George Coukos, Michal Bassani‐Sternberg, P. Filippakopoulos, David Gfeller	35
5	Broad and Conserved Immune Regulation by Genetically Heterogeneous Melanoma Cells 2017 ·Cancer Research ·Natalie J. Neubert, Laure Tillé, David Barras, Charlotte Soneson, Petra Baumgaertner, Donata Rimoldi, David Gfeller, Mauro Delorenzi, Silvia A. Fuertes Marraco, Daniel E. Speiser	8
6	Rapid and Continued T-Cell Differentiation into Long-term Effector and Memory Stem Cells in Vaccinated Melanoma Patients 2016 ·Clinical Cancer Research ·Philippe O. Gannon, Petra Baumgaertner, Alexandre Huber, Emanuela M. Iancu, Laurène Cagnon, Samia Abed Maillard, Hélène Maby–El Hajjami, Daniel E. Speiser, Nathalie Rufer	19
7	Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients 2016 ·Frontiers in Immunology ·T. J. Murray, Silvia A. Fuertes Marraco, Petra Baumgaertner, Natacha Bordry, Laurène Cagnon, Alena Donda, Pedro Romero, Grégory Verdeil, Daniel E. Speiser	82
8	Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial 2015 ·Clinical Cancer Research ·Amandine Legat, Hélène Maby–El Hajjami, Petra Baumgaertner, Laurène Cagnon, Samia Abed Maillard, Christine Geldhof, Emanuela M. Iancu, Luc Lebon, Philippe Guillaume, Danijel Dojcinovic, Olivier Michielin, Emanuela Romano, Grégoire Berthod, Donata Rimoldi, Frédéric Triebel, Immanuel F. Luescher, Nathalie Rufer, Daniel E. Speiser	76
9	Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR–Ligand Off-Rates Measurements on Living Cells 2015 ·Cancer Research ·Michaël Hebeisen, Julien Schmidt, Philippe Guillaume, Petra Baumgaertner, Daniel E. Speiser, Immanuel F. Luescher, Nathalie Rufer	38
10	SHP-1 phosphatase activity counteracts increased T cell receptor affinity 2013 ·Journal of Clinical Investigation ·Michaël Hebeisen, Lukas Baitsch, (unknown), Petra Baumgaertner, Pedro Romero, Olivier Michielin, Daniel E. Speiser, Nathalie Rufer	99
11	Prediction of Cross-Recognition of Peptide-HLA A2 by Melan-A-Specific Cytotoxic T Lymphocytes Using Three-Dimensional Quantitative Structure-Activity Relationships 2013 ·PLoS ONE ·(unknown), Vincent Zoete, Sébastien Viatte, Petra Baumgaertner, Pedro M. Sousa Alves, Pedro Romero, Daniel E. Speiser, Olivier Michielin	3
12	A stepwise protocol to coat aAPC beads prevents out-competition of anti-CD3 mAb and consequent experimental artefacts 2012 ·Journal of Immunological Methods ·Silvia A. Fuertes Marraco, Petra Baumgaertner, Amandine Legat, Nathalie Rufer, Daniel E. Speiser	12
13	Extended Co-Expression of Inhibitory Receptors by Human CD8 T-Cells Depending on Differentiation, Antigen-Specificity and Anatomical Localization 2012 ·PLoS ONE ·Lukas Baitsch, Amandine Legat, Leticia Barba, Silvia A. Fuertes Marraco, Jean‐Paul Rivals, Petra Baumgaertner, Céline Christiansen-Jucht, Hanifa Bouzourène, Donata Rimoldi, Hanspeter Pircher, Nathalie Rufer, Maurice Matter, Olivier Michielin, Daniel E. Speiser	141
14	Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients breakdown → 2011 ·Journal of Clinical Investigation ·Lukas Baitsch, Petra Baumgaertner, Estelle Devêvre, Sunil K. Raghav, Amandine Legat, Leticia Barba, Sébastien Wieckowski, Hanifa Bouzourène, Bart Deplancke, Pedro Romero, Nathalie Rufer, Daniel E. Speiser	650
15	Clonotype Selection and Composition of Human CD8 T Cells Specific for Persistent Herpes Viruses Varies with Differentiation but Is Stable Over Time 2009 ·The Journal of Immunology ·Emanuela M. Iancu, Patricia Corthésy, Petra Baumgaertner, Estelle Devêvre, Verena Voelter, Pedro Romero, Daniel E. Speiser, Nathalie Rufer	58
16	Fine Structural Variations of αβTCRs Selected by Vaccination with Natural versus Altered Self-Antigen in Melanoma Patients 2009 ·The Journal of Immunology ·Sébastien Wieckowski, Petra Baumgaertner, Patricia Corthésy, Verena Voelter, Pedro Romero, Daniel E. Speiser, Nathalie Rufer	43
17	IL-12 Controls Cytotoxicity of a Novel Subset of Self-Antigen-Specific Human CD28+ Cytolytic T Cells 2007 ·The Journal of Immunology ·Catherine Barbey, Petra Baumgaertner, Estelle Devêvre, Verena Rubio‐Godoy, Laurent Derré, Gabriel Bricard, Philippe Guillaume, Immanuel F. Luescher, Danielle Líénard, Jean‐Charles Cerottini, Pedro Romero, Nathalie Rufer, Daniel E. Speiser	14
18	In Vivo Persistence of Codominant Human CD8+ T Cell Clonotypes Is Not Limited by Replicative Senescence or Functional Alteration 2007 ·The Journal of Immunology ·Laurent Derré, (unknown), Petra Baumgaertner, Estelle Devêvre, Patricia Corthésy, Cédric Touvrey, Yolanda D. Mahnke, Hanspeter Pircher, Verena Voelter, Pedro Romero, Daniel E. Speiser, Nathalie Rufer	23
19	Soluble MHC-Peptide Complexes Containing Long Rigid Linkers Abolish CTL-Mediated Cytotoxicity 2006 ·The Journal of Immunology ·Georgi S. Angelov, Philippe Guillaume, Marek Cebecauer, Giovanna Bosshard, Danijel Dojcinovic, Petra Baumgaertner, Immanuel F. Luescher	20
20	The β1 and β3 Integrins Promote T Cell Receptor-mediated Cytotoxic T Lymphocyte Activation 2003 ·Journal of Biological Chemistry ·Marie‐Agnès Doucey, Daniel F. Legler, Mustapha Faroudi, Nicole Boucheron, Petra Baumgaertner, Dieter Naeher, Marek Cebecauer, Denis Hudrisier, Curzio Rüegg, Ed Palmer, Salvatore Valitutti, Claude Bron, Immanuel F. Luescher	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact